Calorie restriction and fasting, whether for 12 or more hours every night or occasionally for longer periods, can contribute to lower body weight, blood sugar, and insulin resistance, plus fewer unpleasant chemotherapy-related side effects.

Are you a health professional?

This section does not replicate the other information on this topic but provides additional details or context most relevant to professionals.

Modes of action

Fasting acts by upsetting nutrition to cancer cells. “The vulnerability of cancer cells to nutrient deprivation and their dependency on specific metabolites are emerging hallmarks of cancer.”1Nencioni A, Caffa I, Cortellino S, Longo VD. Fasting and cancer: molecular mechanisms and clinical application. Nature Reviews. Cancer. 2018;18(11):707–719.

  • “A calorically restricted diet reduced the availability of fatty acids, and this was linked to a slowdown in tumor growth.”2How Does Diet Affect the Growth of Tumors? based on Lien EC, Westermark AM et al. Low glycaemic diets alter lipid metabolism to influence tumour growth. Nature. 2021 Nov;599(7884):302-307.
  • Fasting and fasting-mimicking diets (FMDs) “promote differential effects in normal and malignant cells. These effects are caused in part by the reduction in IGF-1, insulin, and glucose and the increase in IGFBP1 and ketone bodies, which generate conditions that force cancer cells to rely more on metabolites and factors that are limited in the blood, thus resulting in cell death.”3Buono R, Longo VD. Starvation, stress resistance, and cancer. Trends in Endocrinology and Metabolism. 2018;29(4):271–280.
  • Fasting promotes reduced levels of glucose and IGF-1.4Brandhorst S. Longo VD. Fasting and caloric restriction in cancer prevention and treatment. Recent Results Cancer Research. 2016;207:241-66.
  • Fasting is one approach to alter aberrant metabolism, which was once seen just as an epiphenomenon of oncogenic reprogramming but plays a key role in oncogenesis with the power to control both genetic and epigenetic events in cells.5Hirschey MD, DeBerardinis RJ et al; Target Validation Team. Dysregulated metabolism contributes to oncogenesis. Seminars in Cancer Biology. 2015 Dec;35 Suppl:S129-S150.

Fasting may also have other more diffuse metabolic effects.

  • “Fasting suppressed M2 polarization of tumor-associated macrophages to inhibit tumor growth through decreasing the level of adenosine in the tumor microenvironment.”6Sun P, Wang H et al. Fasting inhibits colorectal cancer growth by reducing M2 polarization of tumor-associated macrophages. Oncotarget. 2017;8(43):74649–74660. 
  • Fasting plays a “role in adaptive cellular responses that reduce oxidative damage and inflammation, optimize energy metabolism and bolster cellular protection.”7Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metabolism. 2014 Feb 4;19(2):181-92.
  • “Prolonged fasting reduces circulating IGF-1 levels and PKA activity in various cell populations.”8Cheng CW, Adams Gregor B et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014;14:810–823.
  • Calorie restriction “results in a consistent reduction in circulating levels of growth factors, anabolic hormones, inflammatory cytokines and oxidative stress markers associated with various malignancies.”9Longo VD, Fontana L. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends in Pharmacological Sciences. 2010 Feb;31(2):89-98.
  • “The PI3K pathway is a major determinant of the sensitivity of tumours to DR [dietary restriction] and activating mutations in the pathway may influence the response of cancers to DR-mimetic therapies.”10Kalaany NY, Sabatini DM. Tumours with PI3K activation are resistant to dietary restriction. Nature. 2009 Apr 9;458(7239):725-31.

A range of mechanisms have been proposed for the role of fasting and calorie restriction on extending life. None of these proposed mechanisms so far are entirely supported by evidence.11Masoro EJ. Overview of caloric restriction and ageing. Mechanisms of Ageing and Development. 2005 Sep;126(9):913-22.

Preclinical evidence

Noteworthy preclinical evidence is summarized here. Clinical evidence is described in How can fasting or calorie restriction help you? What the research says ›

Improving treatment outcomes

Cancer as a whole

Survival

  • Reducing glucose and IGF-1 promotes cancer-free survival among animal models.12Buono R, Longo VD. Starvation, stress resistance, and cancer. Trends in Endocrinology and Metabolism. 2018;29(4):271–280.

Enhancing anticancer therapies

  • Fasting or fasting-mimicking diets “increase resistance to chemotherapy in normal but not cancer cells and promote regeneration in normal tissues.”13Nencioni A, Caffa I, Cortellino S, Longo VD. Fasting and cancer: molecular mechanisms and clinical application. Nature Reviews. Cancer. 2018;18(11):707–719.
  • Fasting (short-term starvation) protects healthy cells but not cancer cells against chemotherapy.14Raffaghello L, Lee C, Safdie FM, et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(24):8215–8220.
  • Fasting enhances the anticancer effects of vitamin C, “an effect further potentiated by chemotherapy.”15Di Tano M, Raucci F et al. Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers. Nature Communications. 2020;11(1):2332.

Brain cancer

  • Dietary caloric restriction had “antiangiogenic and proapoptotic effects in the three distinct brain tumor models.”16Mukherjee P, Abate LE, Seyfried TN. Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clinical Cancer Research. 2004;10:5622–5629.
  • Calorie restriction led to less tumor growth and invasion in mice with glioblastoma multiforme.17Shelton LM, Huysentruyt LC, Mukherjee P, Seyfried TN. Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse. ASN Neuro. 2010;2:171–176.

Breast cancer

  • “A fasting-mimicking diet (FMD) increases the levels of bone marrow common lymphoid progenitor cells (CLP) and cytotoxic CD8+ tumor-infiltrating lymphocytes (TILs), leading to a major delay in breast cancer and melanoma progression.”18Di Biase S, Lee C et al. Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer Cell. 2016 Jul 11;30(1):136-146.

Colorectal cancer

  • “Glucose starvation potentiated the efficacy of MeV-mediated cell killing in CRC cells.”19Scheubeck G, Berchtold S et al. Starvation-induced differential virotherapy using an oncolytic measles vaccine virus. Viruses. 2019;11(7):614.
  • “Alternate day fasting for 2 weeks inhibited the tumor growth of mice without causing a reduction of body weight.”20Sun P, Wang H, He Z, et al. Fasting inhibits colorectal cancer growth by reducing M2 polarization of tumor-associated macrophages. Oncotarget. 2017;8(43):74649–74660.
  • “Transcriptional changes after PBF [preconditioning by fasting] to irinotecan treatment showed an improved protective stress response in healthy liver but not in tumor tissue, including changes in irinotecan metabolism.”21Jongbloed F, Huisman SA, van Steeg H, et al. The transcriptomic response to irinotecan in colon carcinoma bearing mice preconditioned by fasting. Oncotarget. 2019;10(22):2224–2234.

Melanoma

  • “A fasting-mimicking diet (FMD) increases the levels of bone marrow common lymphoid progenitor cells (CLP) and cytotoxic CD8+ tumor-infiltrating lymphocytes (TILs), leading to a major delay in breast cancer and melanoma progression.”22Di Biase S, Lee C et al. Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer Cell. 2016 Jul 11;30(1):136-146.

Prostate cancer

  • Intermittent fasting (intermittent caloric restriction) providing greater protective effect compared to chronic calorie restriction in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice.23Bonorden MJ, Rogozina OP, Kluczny CM, Grossmann ME, Grambsch PL, Grande JP, et al. Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice. Nutrition and Cancer. 2009;61:265–275.

Optimizing body terrain

Helpful links

Keep reading about fasting or calorie restriction

Author

Nancy Hepp, MS

Lead Researcher
View profile

Ms. Hepp is a researcher and communicator who has been writing and editing educational content on varied health topics for more than 20 years. She serves as lead researcher and writer for CancerChoices and also served as the first program manager. Her graduate work in research and cognitive psychology, her master’s degree in instructional design, and her certificate in web design have all guided her in writing and presenting information for a wide variety of audiences and uses. Nancy’s service as faculty development coordinator in the Department of Family Medicine at Wright State University also provided experience in medical research, plus insights into medical education and medical care from the professional’s perspective.

Nancy Hepp, MS Lead Researcher

Reviewer

Susan Yaguda, MSN, RN

Manager at Atrium Health’s Levine Cancer Institute and CancerChoices Clinical Consultant
View profile

Susan Yaguda, MSN, RN, has been a nurse for nearly 40 years, working in a variety of healthcare settings. She currently works in Charlotte, North Carolina, at Atrium Health’s Levine Cancer Institute as the manager for Integrative Oncology and Cancer Survivorship. She works with a multidisciplinary team to deliver holistic, evidence-based support and education for patients and care partners at any point along the trajectory of cancer care. She completed the Integrative Oncology Scholars Program through the University of Michigan in 2020, is certified as an Integrative Health Coach through Duke Integrative Medicine and has a post-graduate certificate in Nursing Education from the University of North Carolina, Charlotte. Susan also was awarded the Planetree International Scholar’s Award in 2018 and was recognized by the Daisy Foundation for Nurse Leadership in 2021. Susan has a particular interest in empowering patients and care partners with knowledge to help drive informed decision making and educating nurses on the benefits of integrative care for patients and self-care. She has presented nationally and internationally on integrative oncology and nursing education.

She and her husband, Mark, have two adult children and a very spoiled foxhound. She enjoys hiking, knitting, cooking, and pickleball.

“As a frequent consumer of Beyond Conventional Cancer Therapies, and now CancerChoices, for both professional education and patient support, it is an honor to have the opportunity to engage with the dedicated team at CancerChoices to serve those impacted by this disease.”  

 

Susan Yaguda, MSN, RN Manager at Atrium Health’s Levine Cancer Institute and CancerChoices Clinical Consultant

Last update: May 9, 2024

Last full literature review: April 2023

We are grateful for research support from Dr. Irfan Siddique and Adriana Gutierrez Galvis.

CancerChoices provides information about integrativein cancer care, a patient-centered approach combining the best of conventional care, self care, and evidence-informed complementary care in an integrated plan cancer care. We review complementaryin cancer care, complementary care involves the use of therapies intended to enhance or add to standard conventional treatments; examples include supplements, mind-body approaches such as yoga or psychosocialtherapy, and acupuncture therapies and self carelifestyle actions and behaviors that may impact cancer outcomes; examples include eating health-promoting foods, limiting alcohol, increasing physical activity, and managing stress practices to help patients and professionals explore and integrate the best combination of conventionalthe cancer care offered by conventionally trained physicians and most hospitals; examples are chemotherapy, surgery, and radiotherapy and complementary therapies and practices for each person.

Our staff have no financial conflicts of interest to declare. We receive no funds from any manufacturers or retailers gaining financial profit by promoting or discouraging therapies mentioned on this site.

Learn more

Health professional comment

We invite health professionals to contribute expertise or send us questions.

"*" indicates required fields

Please share your thoughts about content on the CancerChoices website. If you have a correction for us to consider, or additional information to add, please include references and links if possible.

References[+]